跳至主要内容
临床试验/NCT02253966
NCT02253966已完成2 期

Preoperative Intraarticular Injection of Methylprednisolone in Patients Scheduled for Total Knee-arthroplasty

Rigshospitalet, Denmark1 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2014年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
48
试验地点
1
主要终点
Pain

研究概览

简要总结

Despite improvements in analgesic treatment following total knee arthroplasty (TKA) for osteoarthrosis, a substantial part of patients still have severe acute pain after surgery. It has been suggested that preoperative degree of intraarticular inflammation is associated to postoperative degree of pain and level of function. Furthermore it is known, that patients with preoperative inflammation have hyperalgesia and severe movement related pain.

The aim of this study is to investigate the effect of a preoperative intraarticular injection of Methylprednisoloneacetate in reducing acute postoperative pain after total knee arthroplasty in patients with signs of severe pre-operative inflammation and pain.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
50 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 50 -80
  • Osteoarthrosis
  • Scheduled for primary unilateral TKA
  • Preoperative pain report with NRS > 5 upon walking
  • Signs of sensitisation in knee

排除标准

  • Allergies to methylprednisoloneacetate, lidocaine or standard analgesic treatment
  • Deficient written or spoken danish
  • Impairment from psychological or neurological disease
  • Local og systemic infection
  • Immunodeficiency
  • Treatment with corticosteroid within 30 days of inclusion
  • Insulin treated diabetes mellitus
  • Anticoagulant therapy
  • ASA (American Society of Anaesthesia) class > 3
  • General anaesthesia
  • Alchohol use > 21 units / week
  • Pregnancy

研究组 & 干预措施

Methylprednisoloneacetate

Active Comparator

Administration of:

1 ml methylprednisoloneacetate 40 mg/ml 5 ml lidocaine 20 mg/ml 4 ml sodium chloride 9 mg/ml as a single intraarticular injection 7 days prior to surgery.

干预措施: Methylprednisoloneacetate (Drug)

Methylprednisoloneacetate

Active Comparator

Administration of:

1 ml methylprednisoloneacetate 40 mg/ml 5 ml lidocaine 20 mg/ml 4 ml sodium chloride 9 mg/ml as a single intraarticular injection 7 days prior to surgery.

干预措施: Lidocaine (Drug)

Methylprednisoloneacetate

Active Comparator

Administration of:

1 ml methylprednisoloneacetate 40 mg/ml 5 ml lidocaine 20 mg/ml 4 ml sodium chloride 9 mg/ml as a single intraarticular injection 7 days prior to surgery.

干预措施: sodium chloride (Other)

Sodium chloride

Placebo Comparator

Administration of:

5 ml lidocaine 20 mg/ml 5 ml sodium chloride 9 mg/ml as a singe intraarticular injection 7 days prior to surgery.

干预措施: Lidocaine (Drug)

Sodium chloride

Placebo Comparator

Administration of:

5 ml lidocaine 20 mg/ml 5 ml sodium chloride 9 mg/ml as a singe intraarticular injection 7 days prior to surgery.

干预措施: sodium chloride (Other)

结局指标

主要结局

Pain

时间窗: 24 hours postoperatively

Pain intensity on a numeric rang scale (NRS) from 0 to 10 upon ambulation 24 hours following surgery

次要结局

  • Sensitisation(On day 0 and day 2)
  • Pain(From day 1 to day 14)
  • Inflammation(On day 0)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Iben Engelund Luna

MD, Research Fellow

Rigshospitalet, Denmark

研究点 (1)

Loading locations...

相似试验